Left atrial enlargement and stroke recurrence: the Northern Manhattan Stroke Study

S Yaghi, YP Moon, C Mora-McLaughlin, JZ Willey… - Stroke, 2015 - Am Heart Assoc
Background and Purpose— Although left atrial enlargement (LAE) increases incident stroke
risk, the association with recurrent stroke is less clear. Our aim was to determine the …

[HTML][HTML] Cervical artery dissection: a review of the epidemiology, pathophysiology, treatment, and outcome

CA Blum, S Yaghi - Archives of neuroscience, 2015 - ncbi.nlm.nih.gov
Results This paper highlights the mechanisms of cervical artery dissection and stroke in
patients with dissection as well as the natural history and treatment. Conclusion Given the …

Treatment and outcome of hemorrhagic transformation after intravenous alteplase in acute ischemic stroke: a scientific statement for healthcare professionals from the …

S Yaghi, JZ Willey, B Cucchiara, JN Goldstein… - Stroke, 2017 - Am Heart Assoc
Purpose— Symptomatic intracranial hemorrhage (sICH) is the most feared complication of
intravenous thrombolytic therapy in acute ischemic stroke. Treatment of sICH is based on …

Direct oral anticoagulants versus warfarin in the treatment of cerebral venous thrombosis (ACTION-CVT): a multicenter international study

S Yaghi, L Shu, E Bakradze, S Salehi Omran, JA Giles… - Stroke, 2022 - Am Heart Assoc
Background: A small randomized controlled trial suggested that dabigatran may be as effective
as warfarin in the treatment of cerebral venous thrombosis (CVT). We aimed to compare …

Management of central retinal artery occlusion: a scientific statement from the American Heart Association

…, L Sobrin, SI Tjoumakaris, CM Weyand, S Yaghi… - Stroke, 2021 - Am Heart Assoc
Purpose: Central retinal artery occlusion (CRAO) is a form of acute ischemic stroke that
causes severe visual loss and is a harbinger of further cerebrovascular and cardiovascular …

SARS-CoV-2 and stroke in a New York healthcare system

S Yaghi, K Ishida, J Torres, B Mac Grory, E Raz… - Stroke, 2020 - Am Heart Assoc
Background and Purpose: With the spread of coronavirus disease 2019 (COVID-19) during
the current worldwide pandemic, there is mounting evidence that patients affected by the …

Treatment and outcome of thrombolysis-related hemorrhage: a multicenter retrospective study

S Yaghi, AK Boehme, J Dibu, CRL Guerrero… - JAMA …, 2015 - jamanetwork.com
Importance Treatments for symptomatic intracerebral hemorrhage (sICH) are based on expert
opinion, with limited data available on efficacy. Objective To better understand the natural …

A prospective study of neurologic disorders in hospitalized patients with COVID-19 in New York City

…, T Zhou, DE Kahn, BM Czeisler, J Torres, S Yaghi… - Neurology, 2021 - AAN Enterprises
Objective To determine the prevalence and associated mortality of well-defined neurologic
diagnoses among patients with coronavirus disease 2019 (COVID-19), we prospectively …

Symptomatic intracerebral hemorrhage in acute ischemic stroke after thrombolysis with intravenous recombinant tissue plasminogen activator: a review of natural …

S Yaghi, A Eisenberger, JZ Willey - JAMA neurology, 2014 - jamanetwork.com
Importance Intravenous thrombolysis remains the mainstay treatment for acute ischemic
stroke. One of the most feared complications of the treatment is thrombolysis-related …

Ischaemic stroke on anticoagulation therapy and early recurrence in acute cardioembolic stroke: the IAC study

S Yaghi, N Henninger, JA Giles, CL Guerrero… - Journal of Neurology …, 2021 - jnnp.bmj.com
Background and purpose A subset of ischaemic stroke patients with atrial fibrillation (AF)
have ischaemic stroke despite anticoagulation. We sought to determine the association …